Computer modelling of various dose modifications suggests that a loading dose of 400 mg and a maintenance dose of 200 mg twice daily is sufficient to maintain a mean plasma acyclovir level of 6.4 /- 0.8 microM. A further loading dose (400 mg) after dialysis would raise the residual acyclovir concentration by 6.1 /- 1.0 microM.
In the HEDS II study, a maintenance dose of either 400mg of acyclovir BID or 500mg valacyclovir QD for 12 months after resolution of the initial
Maintenance treatment (alternative to valacyclovir): Begin after 10- to 14-day course of IV acyclovir: Oral: 20 mg/kg/dose 4 times daily for 4 to 6 weeks.
acyclovir) (2× maintenance dose) twice a day (BID) will be employed, followed by 15 weeks of maintenance dose of antiviral drug (famciclovir or acyclovir) BID.
by MA Lemak 2024 Cited by 103Four patients were treated with a maintenance dose of acyclovir for periods ranging from 10 to 26 months; there were no significant side effects from the
by P Sirota 2024 Cited by 27HIV-Infected Intravenous Drug Users in Methadone Maintenance Treatment Go to Effect of Long-Term, Low-Dose Acyclovir Suppressive Therapy on
Initial treatment: IV: 10 to 15 mg/kg/dose every 8 hours for 10 to 14 days. Note: Follow up IV therapy with oral acyclovir or valacyclovir maintenance therapy. Maintenance treatment: Begin after 10- to 14-day course of IV acyclovir: Oral: 20 mg/kg/dose 4 times daily for 4 to 6 weeks. HSV prophylaxis; immunocompromised hosts, seropositive:
Study with Quizlet and memorize flashcards containing terms like What is the trade name for acyclovir?, What routes can acyclovir be given by?, What indication is acyclovir used for? and more. Scheduled maintenance: J from to
Note: Follow up IV therapy with oral acyclovir or valacyclovir maintenance therapy. Maintenance treatment: Begin after 10- to 14-day course of IV acyclovir: Oral: 20 mg/kg/dose 4 times daily for 4 to 6 weeks. HSV prophylaxis; immunocompromised hosts, seropositive: Hematopoietic stem cell transplant (HSCT) in seropositive recipient (Tomblyn 2024):
Comments